UPDATE : Tuesday, October 15, 2019
상단여백
Merck Korea forcefully shuts down general medicine biz
Merck Biopharma Korea said it would complete shutting down the General Medi...
by Kim Yun-mi  |  2019-10-15 15:51
라인
Galderma Korea’s key strategy: choice and concentration
Galderma recently debuted as the world’s largest independent dermatology co...
by Kim Yun-mi  |  2019-10-15 13:56
라인
Medytox, Daewoong still in dispute over Nabota's spore appraisal
Medytox and Daewoong Pharmaceutical continued to brawl over the origin of t...
by Lee Han-soo  |  2019-10-15 11:28
라인
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients
The Korean branch of Eli Lilly said it has presented the phase 4 IXORA-R st...
by Lee Han-soo  |  2019-10-14 18:01
라인
HanAll's Chinese partner ends P2 trial of dry eye treatment
HanAll Biopharma said that Harbour Biomed, its Chinese partner, has complet...
by Lee Han-soo  |  2019-10-14 14:08
라인
[Special] How are Korean employees coping with big-pharma M&As?
Since multinational pharmaceutical companies announced merger and acquisiti...
by Kim Yun-mi  |  2019-10-14 13:45
라인
Sanofi releases data showing improved survival for prostate cancer treatment
Sanofi said that it has published research results confirming a longer radi...
by Lee Han-soo  |  2019-10-14 12:16
라인
Regulator keeps Kolon Tissuegene listed with 1-year grace period
The Korean Exchange (KRX) decided to keep Kolon Tissuegene listed on the Ko...
by Lee Han-soo  |  2019-10-12 09:41
라인
GC to market Merck's diabetes treatment
Merck Biopharma Korea said that GC would market Glucophage, its diabetes tr...
by Lee Han-soo  |  2019-10-11 18:13
라인
Bayer drugs out of stock in Korea
Bayer is having trouble supplying its drug in the local market as the compa...
by Lee Han-soo  |  2019-10-11 16:36
라인
Sanofi to cover part of Dupixent cost for atopic dermatitis patients
Sanofi said it would run a program to support part of the cost of Dupixent,...
by Kim Yun-mi  |  2019-10-11 15:13
라인
Takeda Korea’s labor union goes on strike
The conflict between Takeda Korea's management and labor union has reac...
by Lee Han-soo  |  2019-10-11 14:33
라인
Roche’s Tecentriq combo therapy shows encouraging results
Roche Korea said the company had presented results from a phase 1b study ev...
by Lee Han-soo  |  2019-10-10 17:36
라인
Yuyu confirms safety of its antiplatelet drug
Yuyu Pharmaceutical said that it has confirmed the safety of Yuclid (ingred...
by Lee Han-soo  |  2019-10-10 17:35
라인
Doctors call Boehringer Ingelheim’s Jardiance marketing ‘unethical’
The medical community criticized Boehringer Ingelheim Korea’s recent releas...
by Kim Yun-mi  |  2019-10-10 16:01
라인
FDA OKs AbbVie’s Hepatitis C drug to shorten treatment duration
AbbVie said that the U.S. Food and Drug Administration (FDA) has approved M...
by Lee Han-soo  |  2019-10-08 18:04
라인
Allergan Korea to replace breast implant without time limit
Allergan Korea CEO Kim Ji-hyun said she would lift the two-year time limit ...
by Lee Hye-seon  |  2019-10-08 15:22
라인
Most of weight loss drug Saxenda irregularly distributed
Saxenda, a prescription medicine for weight loss, gained immense popularity...
by Kwak Sung-sun  |  2019-10-08 15:19
라인
Yuyang DNU, NSCI to develop treatment for dry macular degeneration
Yuyang DNU and Neural Stem Cell Institute (NSCI), a U.S. NGO research insti...
by Lee Han-soo  |  2019-10-07 16:54
라인
Sanofi confirms prolonged PFS in patients with advanced gastric cancer
Sanofi has published the results of a clinical trial PRODIGY, which evaluat...
by Lee Han-soo  |  2019-10-07 14:39
여백
여백
여백
Back to Top